Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | GILD | IQV |
|---|
| Close | 147.68 | 268.82 |
| Market Cap | $183B | $44.2B |
| 1M | +6.31% | +11.43% |
| P/E (TTM) | — | 32.3 |
| Forward P/E | 25.3 | 20.7 |
| P/E 5-Yr Percentile | — | 68 |
| P/S | 6.0 | 2.6 |
| P/B | 15.3 | 7.2 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $7.8B | $4.2B |
| Revenue YoY | +10.2% | +8.4% |
| Gross Margin | 79.8% | — |
| Latest Quarter EPS | -8.45 | 1.61 |
| Avg Post-Earnings Move | ±3.8% | ±2.4% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 3.21% |
| 90-Day Net Insider Buying | −$15.4M | −$29.9M |
GILD · Revenue, Last 8 Quarters ($B)
IQV · Revenue, Last 8 Quarters ($B)
